Aarogyamshakti Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -72.96%
(FY 2022)
- Profit -2313.98%
(FY 2022)
- Ebitda -129.93%
(FY 2022)
- Net Worth -23.07%
(FY 2022)
- Total Assets 71.93%
(FY 2022)
About Aarogyamshakti Pharmaceutical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajveer Singh, Seema Singh, Sri Baba, and One other member serve as directors at the Company.
- CIN/LLPIN
U85191UP2013PTC059214
- Company No.
059214
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aarogyamshakti Pharmaceutical?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sri Baba | Director | 10-May-2018 | Current |
Rajveer Singh | Director | 01-Dec-2022 | Current |
Seema Singh | Director | 01-Dec-2022 | Current |
Inder Sharma | Director | 10-May-2018 | Current |
Financial Performance of Aarogyamshakti Pharmaceutical.
Aarogyamshakti Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 72.96% decrease. The company also saw a substantial fall in profitability, with a 2313.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Aarogyamshakti Pharmaceutical?
In 2021, Aarogyamshakti Pharmaceutical had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bestone Healthcare Products Private LimitedActive 4 years 3 months
Rajveer Singh and Seema Singh are mutual person
- Bestone Meest Information Technology Services Private LimitedActive 2 years 11 months
Rajveer Singh and Seema Singh are mutual person
- Bestone Industries Private LimitedActive 9 years 4 months
Rajveer Singh and Seema Singh are mutual person
- Bestone Mines And Minerals Private LimitedActive 9 years 4 months
Rajveer Singh and Seema Singh are mutual person
- Bestone Metals Mining And Exploration Private LimitedActive 5 years 10 months
Rajveer Singh and Seema Singh are mutual person
- Vistrit Finvest Private LimitedActive 28 years 11 months
Rajveer Singh and Seema Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aarogyamshakti Pharmaceutical?
Unlock and access historical data on people associated with Aarogyamshakti Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarogyamshakti Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarogyamshakti Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.